Exelon |
rivastigmine tartrate |
Image:Rivastigmine.png Rivastigmine Systematic (IUPAC) name 2,6-dioxo-4-phenyl-piperidine-3-carbonitrile Identifiers CAS number 123441-03-2 ATC code N06DA03 PubChem 77991 DrugBank APRD00321 Chemical data Formula C14H22N2O2 Mol. weight 250.337 g/mol Pharmacokinetic data Bioavailability 96% Protein binding 40% Metabolism ? Half life 1.5 hours Excretion ? Therapeutic considerations Pregnancy cat. ? Legal status Routes ? Rivast ...
Wikipedia - [full article]
Exelon Clinical Trials
- Study of the Effects of Current Drug Treatments on Levels of Certain Brain Chemicals in Alzheimer's Disease
ClinicalTrials.gov Identifier: NCT00104442 - Completed
Alzheimer's Disease
- Electrophysiologic Measures of Treatment Response in Alzheimer Disease
ClinicalTrials.gov Identifier: NCT00018278 - Completed
Alzheimer Disease
- Investigation into Delay to Diagnosis of Alzheimer's Disease with Exelon (InDDEx)
ClinicalTrials.gov Identifier: NCT00000174 - Completed
Alzheimer Disease; Cognition Disorders
Resources
- Exelon Consumer Information (U.S. Food and Drug Administration)

Not Signed In -

